Qoramollarda laminit kasalligining uchrash darajasi va klinik xususiyatlari
Partner conferences of the International Scientific Journal Research Focus · 13.11.2026 · 1 (10) · 145-148
DOI: 10.66073/refocus-conf/1311026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Partner conferences of the International Scientific Journal Research Focus, online erschienen am 13.11.2026. Verfasst von V.U. Ro‘zimov und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The article describes the occurrence rate and clinical manifestations of laminitis in cattle, as well as important aspects of its diagnosis. In the examined groups in Thailand, subclinical laminitis accounted for 38.8% and 42.0%, while in a sample from the Nairobi area of Kenya the subclinical and chronic forms together accounted for 70.3%. These figures relate to the classifications used in the respective studies and are not applicable as a single indicator for all regions. The need to record changes in the horn layer of the hoof in addition to lameness and to differentiate the type of lesion when assessing laminitis is substantiated.
Zitieren
APA
Ro‘zimov, V., & To‘rabayev, D. (2026). Qoramollarda laminit kasalligining uchrash darajasi va klinik xususiyatlari. Partner conferences of the International Scientific Journal Research Focus, 1(10), 145-148. https://doi.org/10.66073/refocus-conf/1311026
Vancouver
Ro‘zimov V, To‘rabayev D. Qoramollarda laminit kasalligining uchrash darajasi va klinik xususiyatlari. Partner conferences of the International Scientific Journal Research Focus. 2026;1(10):145-148. doi:10.66073/refocus-conf/1311026
BibTeX
@article{Rozimov2026,
author = {Ro‘zimov, V.U. and To‘rabayev, D.},
title = {Qoramollarda laminit kasalligining uchrash darajasi va klinik xususiyatlari},
journal = {Partner conferences of the International Scientific Journal Research Focus},
year = {2026},
volume = {1},
number = {10},
pages = {145--148},
doi = {10.66073/refocus-conf/1311026}
}
EUVIMED